A prometabolite strategy inhibits cardiometabolic disease in an ApoE–/– murine model of atherosclerosis

Butyrate, a microbiome-derived short-chain fatty acid with pleiotropic effects on inflammation and metabolism, has been shown to significantly reduce atherosclerotic lesions, rectify routine metabolic parameters such as low-density lipoprotein cholesterol (LDL-C), and reduce systemic inflammation in...

Descripción completa

Detalles Bibliográficos

Autores principales:	Taryn N. Beckman, Lisa R. Volpatti, Salvador Norton de Matos, Anna J. Slezak, Joseph W. Reda, Ada Weinstock, Leah Ziolkowski, Alex Turk, Erica Budina, Shijie Cao, Gustavo Borjas, Jung Woo Kwon, Orlando deLeon, Kirsten C. Refvik, Abigail L. Lauterbach, Suzana Gomes, Eugene B. Chang, Jeffrey A. Hubbell
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Clinical investigation 2025-08-01
Colección:	JCI Insight
Materias:	Inflammation Therapeutics
Acceso en línea:	https://doi.org/10.1172/jci.insight.191090
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!